FeesSafety
Pluang+

Strive plans to buy 20,000 more Bitcoin aiming for 50% balance-sheet growth.

Market News
22 Oct 2026
Tokenpost
View Source
Bullish
Strive plans to buy 20,000 more Bitcoin aiming for 50% balance-sheet growth.

Strive's CEO announced plans to acquire about 20,000 additional Bitcoin as part of a strategy to grow the company's balance sheet by 50%. This move responds to rising demand for Bitcoin digital credit and pressure from large institutions urging faster expansion. The 20,000 BTC figure is a target for future purchases, not a completed transaction, and the 50% growth refers to overall balance-sheet expansion. These goals highlight Strive's effort to scale up in response to institutional interest in Bitcoin assets.

Strive's plan to add about 20,000 Bitcoin to its holdings provides context for cryptocurrency market activity. For readers following major cryptocurrencies, here is Pluang's market snapshot as of Oct 22, 2026 13:02 WIB: out of 50 priced major cryptocurrencies tradable on Pluang, 10 rose and 39 fell today. Notable movers include UNI (Uniswap) at Rp128.916 with a 1-day change of -3.94% and Pluang order activity of 48% Sell / 52% Buy, COMP (Compound) at Rp449.971 with a 1-day change of -3.73% and Pluang order activity of 24% Sell / 76% Buy, and COTI (COTI) at Rp198 with a 1-day change of -3.08% and Pluang order activity of 62% Sell / 38% Buy.

More News

Privosegtor shows neuroprotective effects in Phase 2 trial for optic neuritis, reducing nerve damage markers.

Privosegtor shows neuroprotective effects in Phase 2 trial for optic neuritis, reducing nerve damage markers.

Oculis Holding AG announced that Privosegtor, in a Phase 2 ACUITY trial, reduced increases in blood biomarkers linked to nerve damage (NfL and GFAP) in patients with optic neuritis compared to placebo. These biomarker improvements support earlier fin...

Company Fundamentals
Bullish
23 minutes ago
Ipsen raises 2026 sales growth forecast to 23% after strong Q3 performance

Ipsen raises 2026 sales growth forecast to 23% after strong Q3 performance

Ipsen reported a 24.6% sales growth at constant exchange rates for the first nine months of 2026, driven by strong performance in Oncology, Rare Disease, and Neuroscience segments. The company upgraded its full-year sales growth guidance to around 23...

Company Fundamentals
Bullish
1 hour ago
Nexans chosen as preferred supplier for Mallorca-Menorca power cable project to boost Balearic Islands' grid resilience.

Nexans chosen as preferred supplier for Mallorca-Menorca power cable project to boost Balearic Islands' grid resilience.

Nexans has been selected by Red Eléctrica as the preferred supplier for the Mallorca-Menorca 3 interconnection project, a key infrastructure initiative aimed at strengthening the electricity network's security and resilience in the Balearic Islands. ...

Market News
Bullish
1 hour ago
Roche posts 7% sales growth in Q3 2026, driven by strong demand for innovative medicines and diagnostics.

Roche posts 7% sales growth in Q3 2026, driven by strong demand for innovative medicines and diagnostics.

Roche reported a 7% sales increase at constant exchange rates in Q3 2026, with a 6% rise for the first nine months, fueled by high demand for key medicines like Xolair, Hemlibra, and Ocrevus. The Pharmaceuticals Division led growth, while Diagnostics...

Company Fundamentals
Bullish
1 hour ago
Nexans chosen as preferred supplier for Mallorca-Menorca power interconnection project with Red Eléctrica.

Nexans chosen as preferred supplier for Mallorca-Menorca power interconnection project with Red Eléctrica.

Nexans has been selected by Red Eléctrica as the preferred supplier for the Mallorca-Menorca 3 interconnection project, aimed at enhancing the electricity network's security and resilience in the Balearic Islands. The project includes a six-month eng...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App